Delivery Order SPE2DB22D1202-SPE2DB25FUHY5
Award Date
11/7/24
Potential Completion Date
11/8/24
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,239.56, is for the delivery of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
This federal contract award, with ID SPE2DB22D1202|SPE2DB23FHPE5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,439.57 Firm Fixed Price delivery order is for the supply of Lamictal 100 mg tablets to support the DLA's medical supply needs. The contract has a completion date of May 12, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,549.68 firm fixed-price delivery order is for the supply of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,603.75 firm fixed-price delivery order is for the supply of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of January 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, valued at $22,501.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4562468216 LAMICTAL 25 MG DISPER TABLET 100S, with a period of performance through October 16, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This contract award, with ID SPE2DB24D1205|SPE2DB25FCUNS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,173.88 firm fixed-price delivery order is for the supply of LAMICTAL 25 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of LAMICTAL 200 MG TABLET 60S to the Defense Logistics Agency (DLA). The $4,220.30 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 11, 2024. The contract has an ultimate completion date of October 15, 2024 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FE7ZC, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,698.40, is a delivery order for the supply of LAMICTAL 150 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price arrangement with an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,875.69 Firm Fixed Price Delivery Order supports the procurement of 4,563,373,292 units of Lamictal 100 mg tablets for the DLA. The contract has a completion date of January 22, 2024 and was awarded on January 19, 2024. There was no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,082.36 with a completion date of October 23, 2023. The contract is for the supply of LAMICTAL 150 MG TABLET 60S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...